Zanamivir Amine is used for the treatment of infections caused by influenza A and influenza B viruses, but in otherwise-healthy individuals, benefits overall appear to be small. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.Reference standards of Zanamivir Amine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(2R,3R,4S)-3-(Acetylamino)-4-amino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2Hpyran-6-carboxylic Acid
Catalogue No.:PA 26 03000
CAS :
Molecular Formula : C11H18N2O7
Molecular Weight : 290.27
N-Cyano Zanamivir Amine Triacetate Methyl Ester
Catalogue No.:PA 26 03510
Molecular Formula : C19H25N3O10
Molecular Weight : 455.42
Zanamivir Amine Triacetate Methyl Ester
Catalogue No.:PA 26 03520
Molecular Formula : C18H26N2O10
Molecular Weight : 430.41
Zanamivir Azide Methyl Ester
Catalogue No.:PA 26 03530
Molecular Formula : C12H18N4O7
Molecular Weight : 330.29
Zanamivir Azide Triacetate Methyl Ester
Catalogue No.:PA 26 03540
Molecular Formula : C18H24N4O10
Molecular Weight : 456.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
